SEC Company Response from Advaxis, Inc. (ADXS) (CIK 0001100397) — Oct 15, 2021
Advaxis, Inc. (ADXS) (CIK 0001100397)
Date: Oct. 15, 2021 · CIK: 0001100397 · Accession: 0001493152-21-025524
AI Filing Summary & Sentiment
File numbers found in text: 333-259065
Show Raw Text
CORRESP
1
filename1.htm
Advaxis,
Inc.
9
Deer Park Drive, Suite K-1
Monmouth
Junction, NJ 08852
October
15, 2021
U.S.
Securities and Exchange Commission
Division
of Corporate Finance
Office
of Life Sciences
100
F Street NE
Washington,
DC 20549
Attention:
David Gessert
VIA
EDGAR
Re:
Advaxis,
Inc. - Withdrawal of Acceleration Request
Amendment
No. 1 to Registration Statement on Form S-4
Filed
October 13, 2021
File
No. 333-259065
Dear
Mr. Gessert:
Reference
is made to our letter, filed as correspondence via EDGAR on October 14, 2021, in which the undersigned registrant, Advaxis, Inc. (the
“Company”), requested acceleration of the effectiveness of the above referenced Registration Statement on Form
S-1 (the “Registration Statement”) to 4:00 p.m. Eastern time on October 15, 2021, or as soon thereafter as
practicable (the “Effective Time”), in accordance with Rule 460 and 461 under the Securities Act of 1933, as
amended.
The
Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw
our request for acceleration of the effective date until further notice from the Company.
Very
Truly Yours,
Advaxis,
Inc.
By:
/s/
Kenneth A. Berlin
Name:
Kenneth
A. Berlin
Title:
President
and Chief Executive Officer
cc:
Morgan, Lewis & Bockius LLP